Streetbeat News

Products Services

NICE

NICE has introduced NICE Enlighten XM, a new addition to its customer experience AI solution, Enlighten. This advancement utilizes large language models to deeply personalize customer journeys by leveraging extensive data memory.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:44 am

NVO

Actylis and Novo Nordisk Pharmatech have entered into an agreement to distribute pharmaceutical grade Benzalkonium Chloride in Germany, Spain, Portugal, the UK, and Ireland. This collaboration aims to supply the pharmaceutical and medical device markets in these regions.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:40 am

ATXS

Astria Therapeutics, Inc. (NASDAQ:ATXS) announced positive initial results from the ALPHA-STAR Phase 1b/2 trial for STAR-0215 in treating hereditary angioedema (HAE). The results showed a significant reduction in monthly attack rates and a favorable safety profile, supporting advancement to Phase 3 development with trials starting in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:40 am

MBRX

Moleculin Biotech announced a positive preliminary update on its lead program MB-106 for Acute Myeloid Leukemia treatment, highlighting a 60% CRc rate with its Annamycin and Cytarabine combination (AnnAraC) in 2nd line AML subjects. The update also noted no signs of cardiotoxicity in all 82 subjects across multiple studies and mentioned the potential for accelerated approval as it advances towards a pivotal AML study in 2024.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:36 am

AAPL

VGT

XLK

Apple Inc (AAPL) is planning to launch its Vision Pro headset in China within the year, as announced by CEO Tim Cook. The headset, priced at $3,500 in the US, marks Apple's entry into the virtual and augmented reality market. Despite a 24% drop in iPhone sales in China and a 13% decrease in revenue to $20.8 billion in the December quarter, Apple remains optimistic about the Chinese market. The stock can be accessed through ETFs like Vanguard Information Tech ETF (VGT) and SPDR Select Sector Fund - Technology (XLK). AAPL shares saw a slight decrease of 0.35% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

March 25, 2024 | 11:34 am

AAPL

BIDU

NVDA

PGJ

SOCL

Baidu, Inc (NASDAQ:BIDU) stock is trading higher due to a partnership with Apple Inc (NASDAQ:AAPL) to provide AI services for iPhone 16 and other products in China. This collaboration, reported by Cailian Press and the Wall Street Journal, also includes the Mac OS and iOS 18, exclusively for China. Baidu's AI capabilities, particularly its Ernie Bot, have been recognized by China's regulatory bodies, positioning it strongly in the competitive AI market. The partnership is seen as a significant endorsement of Baidu's AI advancements. Meanwhile, U.S. sanctions have affected Nvidia Corp (NASDAQ:NVDA), a key AI chip supplier to Apple. Baidu's stock has lost over 33% in value in the last 12 months but is trading higher by 1.18% at $103.39 in premarket trading.

Portfolio Pulse from Anusuya Lahiri

March 25, 2024 | 11:26 am

CMMB

Chemomab Therapeutics Ltd. (NASDAQ:CMMB) has been granted a new European patent for CM-101, its monoclonal antibody in Phase 2 clinical development for treating primary sclerosing cholangitis. The patent strengthens Chemomab's intellectual property for CM-101, which targets CCL24, a key player in fibrosis and inflammation. The global Phase 2 SPRING trial for CM-101 has completed patient enrollment, with results expected by mid-2024.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:09 am

TMCI

Treace Medical Concepts has reached a significant milestone by treating 100,000 patients with its patented Lapiplasty 3D Bunion Correction System, showcasing the system's acceptance and effectiveness in the medical community.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:09 am

VSTO

Vista Outdoor's segment Revelyst has acquired PinSeeker, a simulator off-course golf and connectivity app. PinSeeker, part of the Wasserman portfolio, will be integrated into Foresight Sports within Revelyst's Precision Sports Technology platform. Employees of PinSeeker will relocate to San Diego, the base for Revelyst's platform.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:08 am

NRIX

Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company, is part of an international team awarded in the Cancer Grand Challenges to address pediatric cancers using targeted protein degradation. The team, led by experts from the Children's Hospital of Philadelphia and the University of Würzburg, includes members from 10 institutions across the US, UK, France, Germany, and Austria.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:08 am